Skip to content
2000
Volume 11, Issue 32
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Beyond allopurinol and the well-established uricosuric drugs, several other agents can decrease serum uric acid (SUA) levels, such as losartan, fenofibrate and some non-steroidal anti-inflammatory drugs (NSAIDs). Some of these drugs increase renal urate excretion. Hyperuricaemia and gout are common problems (at least 1% of Western men are affected by gout). Raised SUA levels increase the incidence of acute gout and renal calculi. Hyperuricaemia may also predict an increased risk of vascular events. Therefore, lowering SUA levels is of clinical relevance. In this review we consider the effect on SUA levels of drugs that are prescribed for indications other than treating hyperuricaemia. These drugs may obviate the need for specific treatment (e.g. allopurinol) aimed at lowering SUA levels. Furthermore, because hyperuricaemic patients may already be on several drugs (e.g. due to associated dyslipidaemia, hypertension and/or arthritis) compliance may be improved by avoiding additional medication. The potential for adverse effects associated with polypharmacy would also be decreased.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/138161205774913309
2005-12-01
2025-05-12
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/138161205774913309
Loading

  • Article Type:
    Review Article
Keyword(s): atorvastatin; diuretic; fenofibrate; losartan; NSAID; urate; Uric acid; uricosuric
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test